The role of reproductive psychiatry in women's mental health

Women's Reproductive Mental Health Across the Lifespan

Volumn , Issue , 2014, Pages 301-327

  Dossett, Emily C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930246919     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-05116-1_16     Document Type: Chapter

References (86)

1. ACOG National Committee for Quality Assurance, Physician Consortium for Practice Improvement. Committee Opinion. (2012). Maternity care: Performance Measurement Set Measure #3: Behavioral health risk assessment
2. Almond P. (2009). Postnatal depression: A global public health perspective. Perspectives in Public Health, 129 (5), 221-227
3. American College of Obstetricians and Gynecologists (2011). FAQ057: Premenstrual syndrome
4. American College of Obstetrics and Gynecology. (2002). Exercise during pregnancy and the postpartum period. Washington, DC: Committee on Obstetric Practice. Reaffi rmed 2009
5. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Retrieved from http://dx.doi.org/10.1176/appi.books.9780890425596.910646
6. Anderson E. L. (2009). ECT in pregnancy: A review of the literature from 1941-2007. Psychosomatic Medicine, 71, 235-242
7. Baker-Ericzen M. J., Duenas C., Landsverk J. A., Connelly C. D., Hazen L., & Horwitz S. M. (2012). A collaborative care telemedicine intervention to overcome treatment barriers for Latina women with depression during the perinatal period. Families, Systems & Health, 30 (3), 224-240
8. Bath K. G., Chuang J., Spencer-Segal J. L., Amso D., Altemus M., McEwen B. S., & Lee F. S. (2012). Variant brain-derived neurotrophic factor (Valine66Methionine) polymorphism contributes to developmental and estrous stage-Specific expression of anxiety-like behavior in female mice. Biological Psychiatry, 72, 499-504
9. Bergink V., Burgerhout K. M., Weigelt K., Pop V. J., De Wit H., Drexhage R. C., Drexhage H. A. (2013). Immune system dysregulation in first-onset postpartum psychosis. Biological Psychiatry, 73 (10), 1000-1007
10. Brizendine L. (2006). The female brain. New York, NY: Broadway Books
11. Bromberger J. T., Schott L. L., Kravitz H. M., Sowers M., Avis N. E., Gold E. B., Matthews K. A. (2010). Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: Results from the Study of Women's Health Across the Nation (SWAN). Archives of General Psychiatry, 67 (6), 598-607
12. Byatt N., Deligiannidis K. M., & Freeman M. P. (2013). Antidepressant use in pregnancy: A critical review focused on risks and controversies. Acta Psychiatrica Scandinavica, 127 (2), 94-114
13. Chen S.-J., Liu Y.-L., & Sytwu H.-K. (2012). Immunologic regulation in pregnancy: From mechanism to therapeutic strategy for immunomodulation. Clinical & Developmental Immunology, 2012, 1-10. Article ID:258391
14. Coern L. A., Grether J. K., Yoshida C. K., Odouli R., & Hendrick V. (2011). Antidepressant use during pregnancy and childhood autism spectrum disorders. Archives of General Psychiatry, 68 (11), 1104-1112
15. Cohen L. S., Altshuler L. L., Harlow B. L., Nonacs R., Newport D. J., Viguera A. C., Stowe Z. N. (2006). Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. Journal of the American Medical Association, 295 (5), 499-507
16. Cooper W. O., Willy M. E., Pont S. J., & Ray W. A. (2007). Increasing use of antidepressants in pregnancy. American Journal of Obstetrics & Gynecology, 196, 544.e1-544.e5
17. Cox J. L., Holden J. M., & Sagovsky R. (1987). Detection of postnatal depression: Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry, 150, 782-786
18. Danhauer S. C., Legault C., Bandos H., Kidwell K., Constantino J., Vaughan L., Shumaker S. (2012). Positive and negative affect, depression, and cognitive processes in the cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) trial. Neuropsychology Development and Cognitive Section B. Aging Neuropsychology and Cognition, 20 (5), 532-552
19. Davis K., Pearlstein T., Stuart S., O'Hara M., & Zlotnick C. (2013). Analysis of brief screening tools for the detection of postpartum depression: Comparisons of the PRAMS 6-item instrument, PHQ-9, and structured interviews. Archives of Women's Mental Health, 16 (4), 271-277
20. De Groot L., Abalovich M., Alexander E. K., Amino N., Barbour L., Cobin R. H., Stagnaro-Green A. (2012). Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society clinical guideline. Journal of Clinical and Endocrinology Metabolism, 97 (8), 2543-2565
21. Deligiannidis K., & Freeman M. (2010). Complementary and alternative medicine for the treatment of depressive disorders in women. Psychiatry Clinics of North America, 33 (2), 441-463
22. Dennis C. L., Dowswell T. (2013). Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression. Cochrane Database Systematic Reviews, (4), CD006795. doi: 10.1002/14651858.CD006795.pub3
23. Dierckx B., Heijnen W. T., van Den Broek W. W., & Birkenhager T. K. (2012). Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression. Bipolar Disorder, 14 (2), 146-150
24. Earls M. F., & Committee on Psychosocial Aspects of Child and Family Health American Academy of Pediatrics. (2010). Incorporating recognition and management of perinatal and postpartum depression into pediatric practice. Pediatrics, 126 (5), 1032-1039
25. Einarson T. R., Kennedy D., & Einarson A. (2012). Do findings differ across research design?. The case of antidepressant use in pregnancy and malformations. Journal of Popular Therapy Clinical Pharmacology, 19 (2), e334-e348
26. Epperson C. N., & Bale T. L. (2012). BDNF Val66Met polymorphism and brain-derived neurotrophic factor levels across the female life span: Implications for the sex bias in affective disorders. Biological Psychiatry, 72, 434-436
27. Gaynes B. N., Dusetzina S. B., Ellis A. R., Hansen R. A., Farley J. F., Miller W. C., & Sturmer T. (2012). Treating depression after initial treatment failure: Directly comparing switch and augmenting strategies in STAR∗D. Journal of Clinical Psychopharmacology, 32 (1), 114-119
28. Ghanbari Z., Haghollahi F., Shariat M., Foroshani R., & Ashrafi M. (2009). Effects of calcium supplement therapy in women with premenstrual syndrome. Taiwan Journal of Obstetrics & Gynecology, 48 (2), 124-129
29. Grigoriadis S., VonderPorten E. H., Mamisashvili L., Tomlinson G., Dennis C.-L., Koren G., Ross L. E. (2013). The impact of maternal depression during pregnancy on perinatal outcomes: A systematic review and meta-analysis. J ournal of Clinical Psychiatry, 7 4 (4), e321-e341
30. Grote N. K., Bridge J. A., Gavin A. R., Melville J. L., Iyengar S., & Katon W. J. (2010). A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Archives of General Psychiatry, 67 (10), 1012-1024
31. Harrison N. (2013). Infl ammation and mental illness. Journal of Neurological Neurosurgical Psychiatry, 84 (9), e1
32. Hosseini S. M., Bigian M. W., Larkby C., Brooks M. M., Gorin M. B., & Day N. L. (2009). Trait anxiety in pregnant women predicts offspring birth outcomes. Paediatric Perinatal Epidemiology, 23 (6), 557-566
33. Hovington C. L., McGirr A., Lepage M., & Berlim M. T. (2013). Repetitive transcranial magnetic stimulation (rTMS) for treating major depression and schizophrenia: A systematic review of recent meta-analyses. Annals of Medicine, 45 (4), 308-321
34. Kieler H., Artama M., Engeland A., Ericsoon O., Furu K., Gissler M., Haglund B. (2012). Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension of the newborn: A population based cohort study from the fi ve Nordic countries. British Medical Journal, 344, d8012
35. Koren G., & Nordeng H. (2012). Antidepressant use during pregnancy: The risk-benefi t ratio. American Journal of Obstetrics & Gynecology, 207 (3), 157-163
36. Kupka R. W., Altshuler L. L., Nolen W. A., Suppes T., Luckenbaugh D. A., Leverich G. S., Post R. M. (2007). Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disorder, 9 (5), 531-535
37. Lam R. W., Carter D., Misri S., Kuan A. J., Yatham L. N., & Zis A. P. (1999). A controlled study of light therapy in women with late luteal phase dysphoric disorder. Psychiatry Research, 86 (3), 185-192
38. Lanza di Scalea T. (2009). Antidepressant medication use during breastfeeding. Clinical OBGYN, 52 (3), 483-497
39. Lokuge S., Frey B. N., Foster J. A., Soares C. N., & Steiner M. (2011). Depression in women: Windows of vulnerability and new insights into the link between estrogen and serotonin. Journal of Clinical Psychiatry, 72 (11), 1563-1569
40. Los Angeles County Perinatal Mental Health Task Force. (2013). Bringing light to motherhood: Community provider perinatal mental health toolkit (2nd ed.). Los Angeles, CA: Los Angeles County Perinatal Mental Health Task Force
41. Luberto C. M., White C., Sears R. W., & Cotton S. (2013). Integrative medicine for treating depression: An update on the latest evidence. Current Psychiatry Reports, 15 (9), 391. doi: 10.1007/s11920-031-0391-2
42. Lucas M., Asselin G., Merette C., et al. (2009). Effects of ethyl-eicosapentaenoic acid omega-3 fatty acid supplementation on hot fl ashes and quality of life among middle-aged women: A double-blind, placebo-controlled, randomized clinical trial. Menopause, 16 (2), 357-366
43. Malm H., Artama M., Gissler M., & Ritvanen A. (2011). Selective serotonin reuptake inhibitors and risk for major congenital abnormalities. Obstetrics & Gynecology, 118 (1), 111-120
44. Maschi S., Clavenna A., Campi R., Schiavetti B., Bernat M., & Bonati M. (2008). Neonatal outcome following pregnancy exposure to antidepressants: A prospective controlled cohort study. British Journal of Obstetrics & Gynecology, 115, 283-289
45. Massart R., Mongeau R., & Lanfumey L. (2012). Beyond the monoaminergic hypothesis: Neuroplasticity and epigenetic changes in a transgenic mouse model of depression. Philosophical Transactions of the Royal Society B, 367, 2485-2494
46. McCloughen A., & Foster K. (2011). Weight gain associated with taking psychotropic medication: An integrative review. International Journal of Mental Health Nursing, 20 (3), 202-222
47. Milgrom J., Gemmill A. W., Bilszta J. L., Hayes B., Barnett B., Buist A. (2008). Antenatal risk factors for postpartum depression: A large prospective study. Journal of Affective Disorders, 108, 147-157
48. Moses-Kolko E. L., Berga S. L., Kairo B., Sit D. K., & Wisner K. L. (2009). Transdermal estradiol for postpartum depression: A promising treatment option. Clinical Obstetrics & Gynecology, 52 (3), 516-529
49. National Centre for Health and Clinical Excellence. (2007). Antenatal and postnatal mental health: Clinical management and service guidance (CG). London: NICE
50. O'Mahen H., Himle J. A., Gedock G., Henshaw E., & Flynn H. (2013). A pilot randomized controlled trial of cognitive behavioral therapy for perinatal depression adapted for women with low incomes. Depression and Anxiety, 30, 679-687
51. Oats M. P. (2003). Perinatal psychiatric disorders: A leading cause of maternal morbidity and mortality. British Medical Bulletin, 67, 219-229
52. Osborne L. M., & Monk C. (2013). Perinatal depression-The fourth infl ammatory morbidity of pregnancy?: Theory and literature review. Psychoneuroendocrinology, 38 (10), 1929-1952. doi: 10.1016/j.psychneuen.2013.03.019
53. Palmsten K., & Hernandez-Diaz S. (2012). Can non-randomized studies on the safety of antidepressants during pregnancy convincingly beat confounding, chance, and prior beliefs?. Epidemiology, 23 (5), 686-688
54. Papakostas G. I., Shelton R. C., Zajecka J. M., Etamad B., Rickels K., Clain A., Bottiglieri T. (2012). L-Methylfolate as adjunctive therapy for SSRI-resistant major depression: Results of two randomized, double-blind, parallel-sequential trials. American Journal of Psychiatry, 169, 1267-1274
55. Parry B. L., Mahan A. M., Mostofi N., Lew G. S., & Gillin J. C. (1993). Light therapy of late luteal phase dysphoric disorder: An extended study. American Journal of Psychiatry, 150 (9), 1417-1419
56. Pearson R. M., Fernyhough C., Bentall R., Evans J., Heron J., & Joinson C. (2013). Association between maternal depressogenic cognitive style during pregnancy and offspring cognitive style 18 years later. American Journal of Psychiatry, 170 (4), 434-441
57. Pettinati H. M., O'Brien C. P., & Dundon W. D. (2013). Current status of co-occurring mood and substance use disorders: A new therapeutic target. American Journal of Psychiatry, 170, 23-30
58. Pramyothin P., & Khaodhiar L. (2010). Metabolic syndrome with the atypical antipsychotics. Curent Opinions in Endocrinology, Diabetes & Obesity, 17 (5), 460-466
59. Pratt L. A., Brody D. J., & Gu Q. (2011). Antidepressant use in persons aged 12 and over: United States, 2005-2008. NCHS data brief, no 76. Hyattsville, MD: National Center for Health Statistics
60. Rai D., Lee B. K., Dalman C., Golding J., Lewis G., & Manusson C. (2013). Parental depression, paternal antidepressant use during pregnancy, and risk of autism spectrum disorders. British Medical Journal, 346, f2059
61. Rapkin A. J., & Winer S. A. (2008). The pharmacologic management of premenstrual dysphoric disorder. Expert Opinions in Pharmacotherapy, 9 (3), 429-445
62. Ross L. E., Grigoriadis S., Mamishashvili L., Vonderporten E. H., Roerecke M., Rehm J., Chueng A. (2013). Selected pregnancy and delivery outcomes after exposure to antidepressant medication: A systematic review and metaanalysis. Journal of the American Medical Association Psychiatry, 70 (4), 436-443
63. Sandman C. A., Davis E. P., Buss C., & Glynn L. M. (2012). Exposure to prenatal psychobiological stress exerts programming influences on the mother and her fetus. Neuroendocrinology, 95, 8-21
64. Sidebottom A. C., Harrison P. A., Godecker A., & Kim H. (2012). Validation of the Patient Health Questionnaire (PHQ)-9 for prenatal depression screening. Archives of Women's Mental Health, 15 (5), 367-374
65. Soares C. N. (2013). Depression in peri-and postmenopausal women: Prevalence, pathophysiology and pharmacological management. Drugs & Aging, 30 (9), 677-685
66. Sockol L. E., Epperson C. N., & Barber J. P. (2011). A meta-analysis of treatment for perinatal depression. Clinical Psychology Review, 31 (5), 839-849
67. Spinelli M. G. (2009). Postpartum psychosis: Detection of risk and management. American Journal of Psychiatry, 166 (4), 405-408
68. Stahl S. M. (2000). Essential psychopharmacology: Neuroscientifi c basis and practical applications (2nd ed.). Cambridge: Cambridge University Press
69. Sternfeld B., Guthrie K. A., Ensrud K. E., Lacroix A. Z., Larson J. C., Dunn A. L., Caan B. J. (2014). Efficacy of exercise of menopausal symptoms: A randomized controlled trial. Menopause, 21 (4), 330-338
70. Straub H., Adams M., Kim J. J., & Silver R. K. (2012). Antenatal depressive symptoms increase the likelihood of preterm birth. American Journal of Obstetrics & Gynecology, 207 (329), e1-e4
71. Suri R., Hellemann G., Stowe Z. N., Cohen L. S., Aquino A., & Altshuler L. L. (2011). A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infant following prenatal antidepressant exposure. Journal of Clinical Psychiatry, 72 (7), 1002-1007
72. Swalm D., Brooks J., Doherty D., Nathan E., & Jacques A. (2010). Using the Edinburgh postnatal depression scale to screen for perinatal anxiety. Archives of Women's Mental Health, 13, 515-522
73. Topiwala A., Hothi G., & Ebmeier K. P. (2012). Identifying patients at risk of perinatal mood disorders. Practitioner, 256 (1751), 15-18. 2
74. United States Food and Drug Administration. (2013). Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: A propensity-score matched cohort in CPRD. Pharmacoepidemiology and Drug Safety, 22 (9), 942-951
75. USA Preventive Services Task Force. (2009). Screening for depression in adults: U.S. Preventive Services Task Force Recommendations Statement. Annals of Internal Medicine, 151, 784-792
76. van der Wal M. F., van Eijsden M., & Bonsel J. G. (2007). Stress and emotional programs during pregnancy and excessive infant crying. Journal of Developmental Behavioral Pediatrics, 28 (6), 431-437
77. Wisner K. L., Sit K. K., Hanusa B. H., Moses-Kolko E. L., Bogen D. L., Hunker D. F., Singer L. T. (2009). Major depression and antidepressant treatment: Impact on pregnancy and neonatal outcomes. American Journal of Psychiatry, 166, 557-566
78. Wisner K. L., Sit D. K. Y., & Moses-Kolko E. L. (2006). Antipsychotic treatment during pregnancy: A model for decision-making. Advances in Schizophrenia and Clinical Psychiatry, 3 (1), 48-55
79. Wisner K. L., Zarin D. A., Holmboe E. S., Appelbaum P. S., Gelenberg A. J., Leonard H. L., & Frank E. (2000). Risk-benefi t decision making for treatment of depression during pregnancy. American Journal of Psychiatry, 157 (12), 1933-1940
80. World Health Organization. (2009). Mental health aspects of women's reproductive health: A review of the literature. Geneva: WHO Press
81. Yawn B. P., Dietrich A. J., Wollan P., Bertram S., Graham D., Huff J., Pace W. D. (2012). TRIPPD: A practice-based network effectiveness study of postpartum depression screening and management. Annals of Family Medicine, 10, 320-329
82. Yonkers K. A., Norwitz E. R., Smith M. V., Lockwood C. J., Gotman N., Luchansky E., Belanger K. (2012). Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth. Epidemiology, 23 (5), 677-685
83. Yonkers K. A., Pearlstein T. B., & Gotman N. (2013). A pilot study to compare fl uoxetine, calcium, and placebo in the treatment of premenstrual syndrome. Journal of Clinical Psychopharmacology, 33 (5), 614-620
84. Yonkers K. A., Wisner K. L., Stewart D. E., Oberlander T. F., Dell D. L., Stotland N., Lockwood C. (2009). The management of depression during pregnancy: A report from the American Psychiatric Association and the American College of Obstetrics and Gynecology. General Hospital Psychiatry, 31 (5), 403-413
85. Ystrom E. (2012). Breastfeeding cessation and symptoms of anxiety and depression: A longitudinal cohort study. BMC Pregnancy Childbirth, 12 (1), 36
86. Zhang X., Liu K., Sun J., & Zheng Z. (2010). Safety and feasibility of repetitive transcranial magnetic stimulation (rTMS) as a treatment for major depression during pregnancy. Archives of Women's Mental Health, 13 (4), 369-370